Literature DB >> 11869920

Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes.

David C Warner1, Greg Schnepf, Matthew S Barrett, Donald Dian, Nancy L Swigonski.   

Abstract

PURPOSE: To describe NSAID use among football players and examine differences in attitudes and behaviors associated with reports of daily use. Data are from 681 self-administered questionnaires. Independent variables were race (white), insurance status (private), attitudes (whether NSAIDs helped performance), and behaviors (decided independently vs. asked an adult when to take an NSAID, what type, or dose; use of NSAIDs to treat pain vs. block pain). Among NSAID users, independent variables were entered into a logistic regression to determine their effects on the probability of daily use. Athletes were male, 90% white, mean age 15.8 years, and 88% had private insurance. Four-hundred-fifty-two (75%) used NSAIDs in the past 3 months, and 90 (15%) were daily users with no significant difference in age, race, or insurance between users and nonusers. Those who perceived better performance owing to NSAIDs (adjusted odds ratio [AOR] = 2.4), who decided on their own when to take NSAIDs (AOR = 2.2), and who used NSAIDs prophylactically were more likely to use daily NSAIDs (AOR = 2.5) after controlling for other variables in the model. NSAID use in high school football players is highly prevalent. Although package inserts caution against chronic use, nearly one of seven players uses NSAIDs daily. Daily users were more likely to decide independently and to use NSAID prophylactically, raising issues about the need for adult supervision and education of athletes regarding side effects and appropriate use.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869920     DOI: 10.1016/s1054-139x(01)00325-1

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  28 in total

Review 1.  [Interdisciplinary strategies versus doping].

Authors:  Karin Vitzthum; Stefanie Mache; David Quarcoo; David A Groneberg; Norman Schöffel
Journal:  Wien Klin Wochenschr       Date:  2010-06       Impact factor: 1.704

Review 2.  Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?

Authors:  Wilfried Kindermann
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

3.  Use of permitted drugs in Italian professional soccer players.

Authors:  Emanuela Taioli
Journal:  Br J Sports Med       Date:  2007-02-22       Impact factor: 13.800

Review 4.  The use of nonsteroidal anti-inflammatory drugs for exercise-induced muscle damage: implications for skeletal muscle development.

Authors:  Brad J Schoenfeld
Journal:  Sports Med       Date:  2012-12-01       Impact factor: 11.136

5.  Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise.

Authors:  U R Mikkelsen; H Langberg; I C Helmark; D Skovgaard; L L Andersen; M Kjaer; A L Mackey
Journal:  J Appl Physiol (1985)       Date:  2009-08-27

Review 6.  Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis.

Authors:  Peter Jones; Rain Lamdin
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

7.  Ibuprofen before Exercise Does Not Prevent Cortical Bone Adaptations to Training.

Authors:  Vanessa D Sherk; R Dana Carpenter; Erin D Giles; Janine A Higgins; Robera M Oljira; Ginger C Johnson; Samuel Mills; Paul S Maclean
Journal:  Med Sci Sports Exerc       Date:  2017-05       Impact factor: 5.411

Review 8.  Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review.

Authors:  Breton M Asken; Molly J Sullan; Aliyah R Snyder; Zachary M Houck; Vaughn E Bryant; Loren P Hizel; Molly E McLaren; Duane E Dede; Michael S Jaffee; Steven T DeKosky; Russell M Bauer
Journal:  Neuropsychol Rev       Date:  2016-08-25       Impact factor: 7.444

Review 9.  Peptic Ulcer and Exercise.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2017-01       Impact factor: 11.136

10.  Recommendations of the national football league physician society task force on the use of toradol(®) ketorolac in the national football league.

Authors:  Matthew Matava; D Craig Brater; Nancy Gritter; Robert Heyer; Douglas Rollins; Theodore Schlegel; Robert Toto; Anthony Yates
Journal:  Sports Health       Date:  2012-09       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.